Literature DB >> 18608665

Interplay between memory and executive functions in normal and pathological aging.

Patrizia S Bisiacchi1, Erika Borella, Susanna Bergamaschi, Barbara Carretti, Sara Mondini.   

Abstract

Healthy older adults and Alzheimer's disease (AD) patients are reported in the literature to be impaired in memory and executive functions. This research investigates the extent of these two abilities in determining pathological aging. Groups of young-old and old-old healthy people (Experiment 1) and individuals with amnestic mild cognitive impairment (a-MCI) and AD (Experiment 2) were administered verbal and visuo-spatial tests graded for memory and/or executive requirements. Results indicate a decline in visuo-spatial tasks requiring memory and executive functions in healthy aging. The a-MCI showed memory deficits similar to those shown by AD, but preserved executive functions. Executive function decline could be the critical feature of dementia.

Entities:  

Mesh:

Year:  2008        PMID: 18608665     DOI: 10.1080/13803390701689587

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  22 in total

1.  Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan J Teipel
Journal:  Biol Psychiatry       Date:  2011-08-04       Impact factor: 13.382

2.  Age-related differences in working memory: ERPs reveal age-related delays in selection- and inhibition-related processes.

Authors:  Yuji Yi; David Friedman
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2013-09-09

3.  Characterization of cognitive and motor performance during dual-tasking in healthy older adults and patients with Parkinson's disease.

Authors:  Lucia Bartmann Wild; Daiane Borba de Lima; Joana Bisol Balardin; Luana Rizzi; Bruno Lima Giacobbo; Henrique Bianchi Oliveira; Irani Iracema de Lima Argimon; Leonardo Alexandre Peyré-Tartaruga; Carlos R M Rieder; Elke Bromberg
Journal:  J Neurol       Date:  2012-09-29       Impact factor: 4.849

4.  Specific measures of executive function predict cognitive decline in older adults.

Authors:  Lindsay R Clark; Dawn M Schiehser; Gali H Weissberger; David P Salmon; Dean C Delis; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2011-11-24       Impact factor: 2.892

5.  Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment.

Authors:  Lucas S Broster; Juan Li; Charles D Smith; Gregory A Jicha; Frederick A Schmitt; Yang Jiang
Journal:  J Clin Exp Neuropsychol       Date:  2013-09-30       Impact factor: 2.475

6.  Decreased cognitive function in extended family members from the single late-onset-Alzheimer's-disease pedigree.

Authors:  Yan Zeng; Wei Chang; Chang Shu; Lina Ma; Yuanyuan Huang; Ruoshi Wang; Junpeng Zhang; Changcai Zhu; Shawn M McClintock
Journal:  J Int Neuropsychol Soc       Date:  2013-06-07       Impact factor: 2.892

7.  The emergence of cognitive discrepancies in preclinical Alzheimer's disease: a six-year case study.

Authors:  Mark W Jacobson; Dean C Delis; Guerry M Peavy; Spencer R Wetter; Erin D Bigler; Tracy J Abildskov; Mark W Bondi; David P Salmon
Journal:  Neurocase       Date:  2009-04-21       Impact factor: 0.881

Review 8.  Using pictures and words to understand recognition memory deterioration in amnestic mild cognitive impairment and Alzheimer's disease: a review.

Authors:  Brandon A Ally
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

9.  Alzheimer disease alters the relationship of cardiorespiratory fitness with brain activity during the stroop task.

Authors:  Eric D Vidoni; Matthew R Gayed; Robyn A Honea; Cary R Savage; Derek Hobbs; Jeffrey M Burns
Journal:  Phys Ther       Date:  2013-04-04

10.  Characterization of a normal control group: are they healthy?

Authors:  C J Aine; L Sanfratello; J C Adair; J E Knoefel; C Qualls; S L Lundy; A Caprihan; D Stone; J M Stephen
Journal:  Neuroimage       Date:  2013-09-20       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.